8-K: STAAR Surgical Adjusts Executive Compensation
Executive Compensation Update
STAAR Surgical Company announced adjustments to its Interim Co-CEO and CFO's compensation, including a base salary increase and a higher annual bonus target.
Summary
- STAAR Surgical Company's Compensation Committee approved an increase in the annual base salary for Deborah Andrews, Interim Co-Chief Executive Officer and Chief Financial Officer, from $512,000 to $575,000.
- The target annual cash bonus for Ms. Andrews was also increased from 55% to 60% of her base salary.
- These compensation adjustments are effective as of June 8, 2026.
- The changes were based on a review of competitive market compensation data and recognition of Ms. Andrews' contributions to the company's strategic and operational goals.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, primarily an administrative update on executive compensation adjustments that are standard practice.
Positives
- Increased compensation for key executive Deborah Andrews, reflecting recognition of her contributions and competitive market adjustments.
- Base salary increased by $63,000 (approximately 12.3%) to $575,000.
- Annual cash bonus target increased by 5 percentage points to 60% of base salary.
Future Outlook
No specific forward-looking statements or guidance were provided in this filing.
Management Comments
- Compensation adjustments were made following the Committee's review of competitive market compensation data.
- Compensation adjustments were made in recognition of Ms. Andrews' contributions to the Company's strategic and operational objectives.
Industry Context
StockSavvy.ai notes that executive compensation adjustments are common in the medical device industry, particularly for key financial and operational leaders, as companies strive to retain talent and align incentives with strategic goals.
Stakeholder Impact
- Shareholders: The compensation adjustment is a standard business practice and does not immediately indicate a change in company performance, though it reflects investment in leadership.
- Employees: May signal stability and continued focus on strategic execution by leadership.
- Creditors: No direct impact indicated.
Key Dates
| Date | Description |
|---|---|
| June 8, 2026 | Effective date for base salary and annual bonus target increases for Deborah Andrews. |
| June 9, 2026 | Date of the filing and signature by Warren Foust. |
Keywords
STAAR Surgical, Executive Compensation, Deborah Andrews, Form 8-K, Compensation Committee, Base Salary, Annual Bonus
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.